OptimizeRx (OPRX) Retained Earnings (2016 - 2026)
OptimizeRx's Retained Earnings history spans 16 years, with the latest figure at -$79.2 million for Q4 2025.
- On a quarterly basis, Retained Earnings rose 6.08% to -$79.2 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$79.2 million, a 6.08% increase, with the full-year FY2025 number at -$79.2 million, up 6.08% from a year prior.
- Retained Earnings hit -$79.2 million in Q4 2025 for OptimizeRx, up from -$84.3 million in the prior quarter.
- Over the last five years, Retained Earnings for OPRX hit a ceiling of -$35.3 million in Q4 2021 and a floor of -$86.6 million in Q1 2025.
- Historically, Retained Earnings has averaged -$60.2 million across 5 years, with a median of -$58.7 million in 2023.
- Biggest five-year swings in Retained Earnings: tumbled 40.21% in 2024 and later increased 6.08% in 2025.
- Tracing OPRX's Retained Earnings over 5 years: stood at -$35.3 million in 2021, then crashed by 32.45% to -$46.7 million in 2022, then tumbled by 37.62% to -$64.3 million in 2023, then crashed by 31.3% to -$84.4 million in 2024, then increased by 6.08% to -$79.2 million in 2025.
- Business Quant data shows Retained Earnings for OPRX at -$79.2 million in Q4 2025, -$84.3 million in Q3 2025, and -$85.0 million in Q2 2025.